These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12197458)

  • 1. The role of micronutrients as possible mood-stabilizing agents.
    Pies R
    J Clin Psychiatry; 2002 Aug; 63(8):742-3; author reply 743-4. PubMed ID: 12197458
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients.
    McLeod MN; Gaynes BN; Golden RN
    J Clin Psychiatry; 1999 Apr; 60(4):237-40. PubMed ID: 10221284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rapid-cycling bipolar disorder: are antidepressants mood destabilizers?
    Ghaemi SN
    Am J Psychiatry; 2008 Mar; 165(3):300-2. PubMed ID: 18316425
    [No Abstract]   [Full Text] [Related]  

  • 4. Mania and fluvoxamine.
    Burrai C; Bocchetta A; del Zompo M
    Am J Psychiatry; 1991 Sep; 148(9):1263-4. PubMed ID: 1909099
    [No Abstract]   [Full Text] [Related]  

  • 5. Selenium, Vanadium, and Chromium as Micronutrients to Improve Metabolic Syndrome.
    Panchal SK; Wanyonyi S; Brown L
    Curr Hypertens Rep; 2017 Mar; 19(3):10. PubMed ID: 28197835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants in the treatment of bipolar disorder: decoding contradictory evidence and opinion.
    Eppel AB
    Harv Rev Psychiatry; 2008; 16(3):205-9. PubMed ID: 18569041
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic depression in bipolar disorder.
    El-Mallakh RS; Karippot A
    Am J Psychiatry; 2006 Aug; 163(8):1337-41; quiz 1478. PubMed ID: 16877643
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjunctive lamotrigine as a possible mania inducer in bipolar patients.
    Raskin S; Teitelbaum A; Zislin J; Durst R
    Am J Psychiatry; 2006 Jan; 163(1):159-60. PubMed ID: 16390907
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined antidepressant treatment: a risk factor for switching in bipolar patients.
    Gabbay V; O'Dowd MA; Asnis GM
    J Clin Psychiatry; 2002 Apr; 63(4):367; author reply 367-8. PubMed ID: 12000212
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of bipolar depression.
    Dantzler A; Salzman C
    Psychiatr Serv; 1995 Mar; 46(3):229-30. PubMed ID: 7796207
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal and dietary supplements for depression.
    Harv Ment Health Lett; 2008 Oct; 25(4):4-5. PubMed ID: 19024764
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of bipolar disorder, depressed phase augmentation/switching strategies.
    Woggon B
    Mod Probl Pharmacopsychiatry; 1997; 25():78-87. PubMed ID: 9344371
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical issues in managing bipolar depression.
    Kennedy SH; Bradwejn J; Joffe RT; Kusalac M
    Int Clin Psychopharmacol; 1991 Jul; 6 Suppl 1():53-71; discussion 71-2. PubMed ID: 1757719
    [No Abstract]   [Full Text] [Related]  

  • 15. Antidepressants in bipolar depression: much confusion, many questions, few answers.
    Gitlin MJ
    Aust N Z J Psychiatry; 2012 Apr; 46(4):295-7. PubMed ID: 22508587
    [No Abstract]   [Full Text] [Related]  

  • 16. Follow-up and relapse analysis of an inositol study of depression.
    Levine J; Barak Y; Kofman O; Belmaker RH
    Isr J Psychiatry Relat Sci; 1995; 32(1):14-21. PubMed ID: 7622343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products, micronutrients, and nutraceuticals for the treatment of depression: A short review.
    Nabavi SM; Daglia M; Braidy N; Nabavi SF
    Nutr Neurosci; 2017 Apr; 20(3):180-194. PubMed ID: 26613119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing chromium in the fight against diabetes.
    Brown M
    Drug Discov Today; 2003 Nov; 8(21):962-3. PubMed ID: 14643153
    [No Abstract]   [Full Text] [Related]  

  • 19. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds.
    Potter WZ; Ketter TA
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S51-6. PubMed ID: 8500079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.